Gyre Therapeutics, Inc. (GYRE) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 91.73M | 102.37M | 98.58M | 91.28M | 68.45M | 64.79M | 54.81M | 53.52M | 62.72M | 57.22M | 5.13M | 42.08M |
| Cash & Short-Term Investments | 37.5M | 52.42M | 40.4M | 54.37M | 29.89M | 26.67M | 25.09M | 25.1M | 37.35M | 33.51M | 2.23M | 22.17M |
| Cash Only | 37.5M | 37.07M | 40.4M | 36.49M | 15.04M | 11.81M | 15.87M | 16.1M | 29.79M | 33.51M | 2.23M | 21.91M |
| Short-Term Investments | 0 | 15.36M | 0 | 17.87M | 14.85M | 14.86M | 9.23M | 9M | 7.57M | 0 | 0 | 258.54K |
| Accounts Receivable | 22.76M | 36.95M | 25.88M | 25.36M | 22.52M | 29.15M | 20.77M | 19.91M | 16.75M | 16.84M | 1.2M | 12.93M |
| Days Sales Outstanding | 119.32 | 77.69 | 77.11 | 81.37 | 105.41 | 82.4 | 73.42 | 66.12 | 56.24 | 30.57 | 20.28 | 42.24 |
| Inventory | 11.35M | 10.17M | 8.85M | 8.86M | 7.88M | 6.34M | 6.38M | 5.63M | 4.94M | 4.28M | 0 | 5.26M |
| Days Inventory Outstanding | 789.35 | 502.09 | 500.55 | 661.71 | 715.52 | 496.97 | 576.87 | 624.83 | 428.51 | 315.08 | - | 462.49 |
| Other Current Assets | 20.12M | 2.83M | 23.44M | 0 | 0 | 1.44M | 1.51M | 1.72M | 1.9M | 1.04M | 535K | 1 |
| Total Non-Current Assets | 70.28M | 63.76M | 60.81M | 61.36M | 61.34M | 60.62M | 70.43M | 67.41M | 59.29M | 59.32M | 4.83M | 69.14M |
| Property, Plant & Equipment | 23.57M | 24.73M | 23.61M | 23.4M | 23.52M | 25.7M | 26.43M | 25.77M | 23.92M | 23.78M | 0 | 21.9M |
| Fixed Asset Turnover | 0.93x | 1.54x | 1.30x | 1.14x | 0.90x | 1.07x | 0.98x | 1.02x | 1.14x | 1.14x | - | 1.35x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 4.63M | 4.73M | 4.85M | 4.96M | 5.08M | 1.71M | 1.66M | 1.65M | 1.68M | 1.7M | 0 | 25.04M |
| Long-Term Investments | 0 | 0 | 0 | 21.53M | 21.37M | 24.57M | 29.52M | 28.8M | 23.11M | 23.43M | 4.66M | 18.41M |
| Other Non-Current Assets | 34.36M | 27.43M | 25.64M | 5.34M | 5.56M | 3.03M | 7.67M | 6.12M | 5.58M | 5.72M | 168K | 3.79M |
| Total Assets | 162.01M | 166.13M | 159.38M | 152.65M | 129.79M | 125.41M | 125.24M | 120.93M | 122.01M | 116.54M | 9.96M | 111.22M |
| Asset Turnover | 0.14x | 0.23x | 0.20x | 0.19x | 0.17x | 0.22x | 0.21x | 0.21x | 0.23x | 0.43x | 0.53x | 0.26x |
| Asset Growth % | 24.83% | 32.48% | 27.26% | 26.23% | 6.38% | 7.61% | 1156.92% | 8.73% | 10.75% | 37.5% | -67.88% | 33.4% |
| Total Current Liabilities | 19.79M | 18.29M | 15.91M | 16.92M | 18.99M | 19.52M | 14.72M | 15.57M | 19.49M | 20.05M | 1.78M | 12.75M |
| Accounts Payable | 265K | 124K | 556K | 71K | 122K | 108K | 303K | 271K | 330K | 355K | 158K | 140.78K |
| Days Payables Outstanding | 14.27 | 17.95 | 17.72 | 7.63 | 11.58 | 16.06 | 27.56 | 35.51 | 31.84 | 18.88 | 11.61 | 17.74 |
| Short-Term Debt | 751K | 636K | 626K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 14K | 0 | 95K | 123K | 156K | 76K | 97K | 75K | 79K | 0 | 0 |
| Other Current Liabilities | 18.77M | 14.57M | 14.73M | 89K | 3K | 5.7M | 14K | 61K | 27K | 648K | 917K | 3.89M |
| Current Ratio | 4.64x | 5.60x | 6.19x | 5.40x | 3.60x | 3.32x | 3.72x | 3.44x | 3.22x | 2.85x | 2.88x | 3.30x |
| Quick Ratio | 4.06x | 5.04x | 5.64x | 4.87x | 3.19x | 2.99x | 3.29x | 3.07x | 2.97x | 2.64x | 2.88x | 2.89x |
| Cash Conversion Cycle | 894.4 | 561.84 | 559.94 | 735.45 | 809.36 | 563.31 | 622.73 | 655.43 | 452.91 | 326.77 | - | 486.98 |
| Total Non-Current Liabilities | 5.24M | 5.56M | 6.06M | 6.28M | 6.5M | 7.49M | 12.05M | 12.01M | 13.75M | 82.54M | 4.66M | 874.48K |
| Long-Term Debt | 72K | 0 | 539K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 303K | 0 | 771K | 780K | 885K | 1.1M | 1.3M | 175K | 199K | 0 | 2.62K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5.17M | 4.41M | 5.52M | 4.63M | 4.81M | 5.67M | 10.76M | 10.52M | 13.38M | 82.13M | 4.66M | 871.86K |
| Total Liabilities | 25.03M | 23.85M | 21.97M | 23.2M | 25.49M | 27M | 26.77M | 27.58M | 33.24M | 102.59M | 6.45M | 13.62M |
| Total Debt | 823K | 939K | 1.17M | 1.39M | 1.58M | 1.6M | 1.79M | 1.96M | 275K | 409K | 0 | 474.33K |
| Net Debt | -36.68M | -36.13M | -39.24M | -35.1M | -13.46M | -10.21M | -14.07M | -14.14M | -29.51M | -33.1M | -2.23M | -21.43M |
| Debt / Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.00x | 0.03x | - | 0.00x |
| Debt / EBITDA | - | 1.15x | 0.15x | 0.50x | 0.56x | 1.50x | 0.38x | 0.56x | 0.03x | - | - | 0.09x |
| Net Debt / EBITDA | - | -44.33x | -5.18x | -12.48x | -4.79x | -9.56x | -2.99x | -4.04x | -3.48x | - | -0.17x | -4.05x |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 136.99M | 142.28M | 137.41M | 129.44M | 104.3M | 98.4M | 98.47M | 93.35M | 88.77M | 13.95M | 3.52M | 97.6M |
| Equity Growth % | 31.34% | 44.59% | 39.54% | 38.67% | 17.5% | 605.44% | 2699.94% | -4.36% | -7.81% | -80.68% | -88.03% | 23.44% |
| Book Value per Share | 1.50 | 1.38 | 1.34 | 1.26 | 1.02 | 0.96 | 0.96 | 0.89 | 0.87 | 0.18 | 0.05 | 1.39 |
| Total Shareholders' Equity | 101.31M | 106.03M | 101.92M | 92.03M | 68.12M | 63.32M | 63.18M | 60.35M | 56.64M | -15.83M | 3.52M | 97.6M |
| Common Stock | 91K | 91 | 91K | 91K | 87K | 86K | 85K | 85K | 85K | 77K | 37K | 8.45M |
| Retained Earnings | -77.67M | -68.43M | -66.7M | -70.31M | -70.75M | -73.45M | -73.35M | -74.48M | -78.01M | -85.54M | -414.72M | 54.56M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 586K | 2.32M | -1.7M | 811K | 612K | 501K | 2.15M | 1.09M | 1.36M | 1.45M | 0 | 34.58M |
| Minority Interest | 35.68M | 36.25M | 35.49M | 37.42M | 36.18M | 35.08M | 35.3M | 32.99M | 32.13M | 29.78M | 0 | 0 |